Recent FDA Oncology Initiatives

Event Date: 5th April 2023

Event Time: 11:00AM EST

Event Location: Webinar

Meet with us Register Today

This presentation will discuss two recent FDA guidance documents issued related to oncology drug development. The first is related to dose optimization for treatment of oncologic disease as part of Project Optimus which was published as draft guidance in January 2023. In this guidance, FDA discusses the issue with Maximum Tolerated Dose (MTD) approach for oncology dose selection and offers recommendations. The second subject is Tissue Agnostic drug development, issued as draft guidance in October 2022. This opens up the opportunity to develop a single treatment for multiple tumor types if they all contain the same specific molecular alteration such as biomarker or pathway.

Clara Li, Vice President Regulatory and Strategic Development,

Clara Li has worked in regulatory affairs for over 30 years, and has expertise in US, European, Canadian, and Asia Pacific regions for Phase 1-4 studies. Her areas of therapeutic expertise include oncology, inflammation, cardiovascular, renal, endocrine, neurology, ophthalmology, infectious diseases, and dermatology. She has held numerous leadership roles in regulatory strategy for development of well-characterized biologics; small molecules; cell, tissue, and gene therapy; microbiome; vaccines; and combination products.  She has developed innovative regulatory paths leading to clinical programs and marketing approval, including successful execution of FDA and EU health authority negotiations, submissions, approvals of clinical trial (IND, CTA) and marketing submissions (NDA, 505(b)2 NDA, BLA, MAA) and life cycle management of dossiers. Clara also has expertise in conducting due diligence for companies buying products as well as out-licensing products including single products, entire product lines, products still in clinical development, and marketed products.

Meet with Us

You might also be interested in

DIA China 2024 Annual Meeting

05/01/24

The upcoming DIA China 2024 Meeting will be held from May ...

Read more

2024 ASCO Annual Meeting

03/18/24

Step into a world of inspiration at the 2024 ASCO Annual M...

Read more

OCT Europe

03/18/24

With regulations ever changing and the innovative advancem...

Read more
Leading a new way

The latest from Caidya

Explore our news and updates as we liberate the clinical research process.

2024 ASCO Annual Meeting

1st June 2024 to 3rd June 2024
Chicago, IL

Pharmaceutical Contract Management Group (PCMG)

5th June 2024 to 6th June 2024
Den Haag, The Netherlands

04/01/2024

Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto

Morrisville, NC, USA, April 1, 2024 - Caidya, a leading...